Literature DB >> 9627649

Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes.

T M Aaberg1, H W Flynn, J Schiffman, J Newton.   

Abstract

OBJECTIVE: The purpose of the study was to evaluate the incidence of acute-onset (within 6 weeks after surgery) postoperative endophthalmitis and to assess the visual acuity outcomes after treatment over a 10-year period at one institution. PATIENTS AND METHODS: This retrospective study reviews all surgical cases performed between January 1, 1984 and December 30, 1994 at the Anne Bates Leach Eye Hospital, Bascom Palmer Eye Institute, University of Miami Medical Center, for the occurrence of nosocomial acute-onset postoperative endophthalmitis.
RESULTS: The overall 10-year incidence of acute-onset postoperative endophthalmitis after intraocular surgery was 0.093% (54/58, 123). The incidences of culture-proven acute-onset postoperative endophthalmitis by surgical category were as follows: cataract surgery with or without intraocular lens (IOL) (0.082%, 34/41, 654), pars plana vitrectomy (PPV) (0.046%, 3/6557), penetrating keratoplasty (0.178%, 5/2805), secondary IOL placement (0.366%, 5/1367), glaucoma surgeries (0.124%, 4/3233), combined trabeculectomy and cataract surgery (0.114%, 2/1743), and combined penetrating keratoplasty and cataract surgery (0.194%, 1/515). The median visual acuity after endophthalmitis treatment was 20/200. The median visual acuities after endophthalmitis treatment by procedure were as follows: cataract surgery with or without IOL (20/133), PPV (no light perception), penetrating keratoplasty (2/200), secondary IOL implantation (20/40), glaucoma surgery (20/80), and combined trabeculectomy and cataract surgery with or without IOL (20/150).
CONCLUSIONS: The overall incidence of endophthalmitis after intraocular surgery was 0.093%. The incidence of endophthalmitis was higher after secondary IOL implantation than after cataract extraction (P = 0.008, Fisher's exact test). After treatment, the visual acuity outcomes were worse in the patients who developed endophthalmitis after PPV than after cataract extraction, glaucoma procedures, or secondary IOL implantation (P < 0.05, analysis of variance, Duncan's multiple range test). Acuity outcomes after treatment of endophthalmitis were better among the patients with secondary IOL implantation than after penetrating keratoplasty or PPV (P < 0.05, analysis of variance, Duncan's multiple range test). The results of this 10-year review from a large teaching center may serve as a source of comparison for other centers and future studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627649     DOI: 10.1016/S0161-6420(98)96000-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  70 in total

1.  The dangers of sublethal carvacrol exposure: increases in virulence of Bacillus cereus during endophthalmitis.

Authors:  Niloofar Rajabli; Lauren Williamson; Pierre S Nimmer; Marie Kelly-Worden; Jill S Bange; Yenling Ho; John L McKillip
Journal:  Int J Biochem Mol Biol       Date:  2018-10-08

Review 2.  The microbiology of endophthalmitis: global trends and a local perspective.

Authors:  Y Keynan; Y Finkelman; P Lagacé-Wiens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-05       Impact factor: 3.267

3.  Infectious Endophthalmitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

4.  Gemella haemolysans acute postoperative endophthalmitis.

Authors:  S V Raman; N Evans; T J Freegard; R Cunningham
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

5.  Postoperative eye protection after cataract surgery.

Authors:  L W Lim; M C Chew; C S Tan
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

6.  Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy.

Authors:  Ingrid U Scott; Harry W Flynn; Nur Acar; Sundeep Dev; Saad Shaikh; Robert A Mittra; J Fernando Arevalo; Andres Kychenthal; Allen Kunselman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-18       Impact factor: 3.117

7.  Survival of bacteria on the ocular surface following double application of povidone-iodine before cataract surgery.

Authors:  C V Stranz; G E Fraenkel; A R Butcher; A J Esterman; M J Goggin
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

8.  Nosocomial postoperative endophthalmitis: a 14-year review.

Authors:  Pei-Chang Wu; Hsi-Kung Kuo; Mien Li; Ing-Chou Lai; Po-Chiung Fang; Sue-Ann Lin; Shyi-Jang Shin; Yung-Jen Chen; Mei-Ching Teng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-14       Impact factor: 3.117

9.  Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.

Authors:  Joshua D Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P Lee; David W Hutton
Journal:  Ophthalmology       Date:  2014-01-07       Impact factor: 12.079

10.  Adverse events after pars plana vitrectomy among medicare beneficiaries.

Authors:  Joshua D Stein; David N Zacks; Daniel Grossman; Hilary Grabe; Mark W Johnson; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.